These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 16214174)
1. Exploiting genotypic differences to identify genes important for EAE development. Jelinsky SA; Miyashiro JS; Saraf KA; Tunkey C; Reddy P; Newcombe J; Oestreicher JL; Brown E; Trepicchio WL; Leonard JP; Marusic S J Neurol Sci; 2005 Dec; 239(1):81-93. PubMed ID: 16214174 [TBL] [Abstract][Full Text] [Related]
2. Characterization of Multiple Sclerosis candidate gene expression kinetics in rat experimental autoimmune encephalomyelitis. Thessen Hedreul M; Gillett A; Olsson T; Jagodic M; Harris RA J Neuroimmunol; 2009 May; 210(1-2):30-9. PubMed ID: 19269041 [TBL] [Abstract][Full Text] [Related]
3. The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Chabas D; Baranzini SE; Mitchell D; Bernard CC; Rittling SR; Denhardt DT; Sobel RA; Lock C; Karpuj M; Pedotti R; Heller R; Oksenberg JR; Steinman L Science; 2001 Nov; 294(5547):1731-5. PubMed ID: 11721059 [TBL] [Abstract][Full Text] [Related]
4. Gene-expression profiling of the early stages of MOG-induced EAE proves EAE-resistance as an active process. Mix E; Ibrahim S; Pahnke J; Koczan D; Sina C; Böttcher T; Thiesen HJ; Rolfs A J Neuroimmunol; 2004 Jun; 151(1-2):158-70. PubMed ID: 15145614 [TBL] [Abstract][Full Text] [Related]
5. Experimental autoimmune encephalomyelitis in NF-kappa B-deficient mice:roles of NF-kappa B in the activation and differentiation of autoreactive T cells. Hilliard B; Samoilova EB; Liu TS; Rostami A; Chen Y J Immunol; 1999 Sep; 163(5):2937-43. PubMed ID: 10453042 [TBL] [Abstract][Full Text] [Related]
6. Regulation of gene expression associated with acute experimental autoimmune encephalomyelitis by Lovastatin. Paintlia AS; Paintlia MK; Singh AK; Stanislaus R; Gilg AG; Barbosa E; Singh I J Neurosci Res; 2004 Jul; 77(1):63-81. PubMed ID: 15197739 [TBL] [Abstract][Full Text] [Related]
7. IL-12/IFN-gamma/NO axis plays critical role in development of Th1-mediated experimental autoimmune encephalomyelitis. Xiao BG; Ma CG; Xu LY; Link H; Lu CZ Mol Immunol; 2008 Feb; 45(4):1191-6. PubMed ID: 17697713 [TBL] [Abstract][Full Text] [Related]
8. Astrocytes stimulate interleukin-17 and interferon-gamma production in vitro. Miljkovic D; Momcilovic M; Stojanovic I; Stosic-Grujicic S; Ramic Z; Mostarica-Stojkovic M J Neurosci Res; 2007 Dec; 85(16):3598-606. PubMed ID: 17969033 [TBL] [Abstract][Full Text] [Related]
9. IFN-gamma is critical to the control of murine autoimmune encephalomyelitis and regulates both in the periphery and in the target tissue: a possible role for nitric oxide. Willenborg DO; Fordham SA; Staykova MA; Ramshaw IA; Cowden WB J Immunol; 1999 Nov; 163(10):5278-86. PubMed ID: 10553050 [TBL] [Abstract][Full Text] [Related]
10. Prevention of experimental allergic encephalomyelitis via inhibition of IL-12 signaling and IL-12-mediated Th1 differentiation: an effect of the novel anti-inflammatory drug lisofylline. Bright JJ; Du C; Coon M; Sriram S; Klaus SJ J Immunol; 1998 Dec; 161(12):7015-22. PubMed ID: 9862738 [TBL] [Abstract][Full Text] [Related]
11. Elevated interferon gamma expression in the central nervous system of tumour necrosis factor receptor 1-deficient mice with experimental autoimmune encephalomyelitis. Wheeler RD; Zehntner SP; Kelly LM; Bourbonnière L; Owens T Immunology; 2006 Aug; 118(4):527-38. PubMed ID: 16780563 [TBL] [Abstract][Full Text] [Related]
12. Interferon-gamma confers resistance to experimental allergic encephalomyelitis. Krakowski M; Owens T Eur J Immunol; 1996 Jul; 26(7):1641-6. PubMed ID: 8766573 [TBL] [Abstract][Full Text] [Related]
13. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis. Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651 [TBL] [Abstract][Full Text] [Related]
14. The effect of gammadelta T cell depletion on cytokine gene expression in experimental allergic encephalomyelitis. Rajan AJ; Klein JD; Brosnan CF J Immunol; 1998 Jun; 160(12):5955-62. PubMed ID: 9637509 [TBL] [Abstract][Full Text] [Related]
15. SJL and NOD macrophages are uniquely characterized by genetically programmed, elevated expression of the IL-12(p40) gene, suggesting a conserved pathway for the induction of organ-specific autoimmunity. Alleva DG; Johnson EB; Wilson J; Beller DI; Conlon PJ J Leukoc Biol; 2001 Mar; 69(3):440-8. PubMed ID: 11261792 [TBL] [Abstract][Full Text] [Related]
16. Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). Ferber IA; Brocke S; Taylor-Edwards C; Ridgway W; Dinisco C; Steinman L; Dalton D; Fathman CG J Immunol; 1996 Jan; 156(1):5-7. PubMed ID: 8598493 [TBL] [Abstract][Full Text] [Related]
17. Critical role of preproenkephalin in experimental autoimmune encephalomyelitis. Weir C; McNeill A; Hook S; Harvie M; La Flamme AC; Le Gros G; Bäckström BT J Neuroimmunol; 2006 Oct; 179(1-2):18-25. PubMed ID: 16904193 [TBL] [Abstract][Full Text] [Related]
18. Do Th2 cells mediate the effects of glatiramer acetate in experimental autoimmune encephalomyelitis? Jee Y; Liu R; Bai XF; Campagnolo DI; Shi FD; Vollmer TL Int Immunol; 2006 Apr; 18(4):537-44. PubMed ID: 16481342 [TBL] [Abstract][Full Text] [Related]
19. Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis. Noorbakhsh F; Tsutsui S; Vergnolle N; Boven LA; Shariat N; Vodjgani M; Warren KG; Andrade-Gordon P; Hollenberg MD; Power C J Exp Med; 2006 Feb; 203(2):425-35. PubMed ID: 16476770 [TBL] [Abstract][Full Text] [Related]
20. Modulation of susceptibility and resistance to an autoimmune model of multiple sclerosis in prototypically susceptible and resistant strains by neutralization of interleukin-12 and interleukin-4, respectively. Constantinescu CS; Hilliard B; Ventura E; Wysocka M; Showe L; Lavi E; Fujioka T; Scott P; Trinchieri G; Rostami A Clin Immunol; 2001 Jan; 98(1):23-30. PubMed ID: 11141323 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]